MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.exger.2025.112689

Медицинская библиотека · Experimental gerontology · 2025

Decreased serum PF4 levels correlate with cognitive decline and CSF biomarkers in Alzheimer's disease in a Chinese cohort.

Sun Hao, Chen Dong-Wan, Ma Yuan-Ye, Liu Bai, Wang Jun, Lai Yu-Jie, Zeng Gui-Hua, Shen Ying-Ying, Tan Cheng-Rong, Bu Xian-Le, Zeng Fan, Wang Yan-Jiang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Platelet factor 4 (PF4), a chemotactic factor secreted from the α-granules of platelets, has recently been proved to mitigate neuroinflammation and improve aging-related cognition decline, which may be involved in Alzheimer's disease (AD).

OBJECTIVE

This study aims to investigate the alterations of serum PF4 levels in AD, the correlation between serum PF4 and β-amyloid (Aβ) and tau levels in cerebrospinal fluid (CSF), and the potential diagnostic utility of PF4 in AD.

METHODS

A cross-sectional study was conducted involving 38 amyloid-positive AD patients and 50 cognitively normal controls. The levels of serum PF4 were detected using the Human CXCL4/PF4 enzyme-linked immunosorbent assay (ELISA) Kit. The levels of CSF Aβ42, Aβ40, p-tau181, and t-tau were measured on the fully-automated Lumipulse G1200 platform via commercially available kits.

RESULTS

The levels of serum PF4 were significantly decreased in AD patients (5163.51 (3198.24-6301.15) vs. 5859.29 (4126.06-8006.70), Z = -2.30, P = 0.021). The negative correlation between AD diagnosis (β = -1972.292, P = 0.009) and PF4 levels retained after the adjustments of age, sex, APOE ε4 status, platelet count, platelet distribution width (PDW), and comorbidity of dyslipidemia in the multiple linear regression analysis. Further analysis showed that serum PF4 levels were positively correlated with CSF Aβ42 levels and Mini-Mental State Examination (MMSE) scores, and negatively correlated with CSF t-tau levels. Besides, the area under the curve (AUC) of serum PF4 for AD (AUC = 0.6437, P = 0.022) was comparable to that of CSF Aβ40 (AUC = 0.6400) yet lower than those of CSF Aβ42, ptau181, and t-tau. The AUC slightly increased when combining serum PF4 with other CSF AD biomarkers separately.

CONCLUSIONS

The serum levels of PF4 were decreased in AD patients and were significantly correlated with the cognitive function and CSF levels of Aβ42 and t-tau. PF4 may become a promising anti-aging and therapeutic target for AD, which is worthy of further study.

Для цитирования: Sun Hao, Chen Dong-Wan, Ma Yuan-Ye, Liu Bai, Wang Jun, Lai Yu-Jie, Zeng Gui-Hua, Shen Ying-Ying, Tan Cheng-Rong, Bu Xian-Le, Zeng Fan, Wang Yan-Jiang. Decreased serum PF4 levels correlate with cognitive decline and CSF biomarkers in Alzheimer's disease in a Chinese cohort.. Experimental gerontology. 2025. DOI: 10.1016/j.exger.2025.112689.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.